Oncology Sponsored Patient Centricity to Integration: Enhancing Cancer Outcomes We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
News Japan follows UK in GSK's comeback tour for Blenrep The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.